ArticleBMJ open2021

Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial.

Kirthi Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.